Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Benign Prostatic Hyperplasia (BPH) Treatment Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Benign Prostatic Hyperplasia (BPH) Treatment Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Benign Prostatic Hyperplasia (BPH) Treatment Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Benign Prostatic Hyperplasia (BPH) Treatment Market-Segmentation by Type 5.1 Alpha Blocker 5.2 5- Alpha Reductase Inhibitor 5.3 Tadalafil 5.4 Others 6 Global Benign Prostatic Hyperplasia (BPH) Treatment Market-Segmentation by Application 6.1 Hospital 6.2 Clinic 7 Global Benign Prostatic Hyperplasia (BPH) Treatment Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Pfizer, Inc. 8.1.1 Pfizer, Inc. Profile 8.1.2 Pfizer, Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Pfizer, Inc. Product/Solution Launches and Enhancements Analysis 8.1.4 Pfizer, Inc. Business Overview/Recent Development/Acquisitions 8.2 Astellas Pharma, Inc. 8.2.1 Astellas Pharma, Inc. Profile 8.2.2 Astellas Pharma, Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 Astellas Pharma, Inc. Product/Solution Launches and Enhancements Analysis 8.2.4 Astellas Pharma, Inc. Business Overview/Recent Development/Acquisitions 8.3 Merck & Co., Inc. 8.3.1 Merck & Co., Inc. Profile 8.3.2 Merck & Co., Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Merck & Co., Inc. Product/Solution Launches and Enhancements Analysis 8.3.4 Merck & Co., Inc. Business Overview/Recent Development/Acquisitions 8.4 Abbott Laboratories 8.4.1 Abbott Laboratories Profile 8.4.2 Abbott Laboratories Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Abbott Laboratories Product/Solution Launches and Enhancements Analysis 8.4.4 Abbott Laboratories Business Overview/Recent Development/Acquisitions 8.5 GlaxoSmithKline plc 8.5.1 GlaxoSmithKline plc Profile 8.5.2 GlaxoSmithKline plc Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 GlaxoSmithKline plc Product/Solution Launches and Enhancements Analysis 8.5.4 GlaxoSmithKline plc Business Overview/Recent Development/Acquisitions 8.6 Allergan plc 8.6.1 Allergan plc Profile 8.6.2 Allergan plc Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Allergan plc Product/Solution Launches and Enhancements Analysis 8.6.4 Allergan plc Business Overview/Recent Development/Acquisitions 8.7 Boehringer Ingelheim Pharma GmbH & Co. KG 8.7.1 Boehringer Ingelheim Pharma GmbH & Co. KG Profile 8.7.2 Boehringer Ingelheim Pharma GmbH & Co. KG Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 Boehringer Ingelheim Pharma GmbH & Co. KG Product/Solution Launches and Enhancements Analysis 8.7.4 Boehringer Ingelheim Pharma GmbH & Co. KG Business Overview/Recent Development/Acquisitions 8.8 Teva Pharmaceutical Industries Limited 8.8.1 Teva Pharmaceutical Industries Limited Profile 8.8.2 Teva Pharmaceutical Industries Limited Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Teva Pharmaceutical Industries Limited Product/Solution Launches and Enhancements Analysis 8.8.4 Teva Pharmaceutical Industries Limited Business Overview/Recent Development/Acquisitions 8.9 Eli Lilly and Company 8.9.1 Eli Lilly and Company Profile 8.9.2 Eli Lilly and Company Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 Eli Lilly and Company Product/Solution Launches and Enhancements Analysis 8.9.4 Eli Lilly and Company Business Overview/Recent Development/Acquisitions 8.10 Sanofi 8.10.1 Sanofi Profile 8.10.2 Sanofi Sales, Growth Rate and Global Market Share from 2014-2019E 8.10.3 Sanofi Product/Solution Launches and Enhancements Analysis 8.10.4 Sanofi Business Overview/Recent Development/Acquisitions 9 Global Benign Prostatic Hyperplasia (BPH) Treatment Market-Segmentation by Geography 10 North America 10.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Production Analysis from 2014-2019E 10.4 North America Benign Prostatic Hyperplasia (BPH) Treatment Consumption Analysis from 2014-2019E 10.5 North America Benign Prostatic Hyperplasia (BPH) Treatment Import and Export from 2014-2019E 10.6 North America Benign Prostatic Hyperplasia (BPH) Treatment Value, Production and Market Share by Type (2014-2019E) 10.7 North America Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Benign Prostatic Hyperplasia (BPH) Treatment by Country (United States, Canada) 10.8.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Sales by Country (2014-2019E) 10.8.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Consumption Value by Country (2014-2019E) 10.9 North America Benign Prostatic Hyperplasia (BPH) Treatment Market PEST Analysis 11 Europe 11.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Production Analysis from 2014-2019E 11.4 Europe Benign Prostatic Hyperplasia (BPH) Treatment Consumption Analysis from 2014-2019E 11.5 Europe Benign Prostatic Hyperplasia (BPH) Treatment Import and Export from 2014-2019E 11.6 Europe Benign Prostatic Hyperplasia (BPH) Treatment Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Benign Prostatic Hyperplasia (BPH) Treatment by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Sales by Country (2014-2019E) 11.8.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Consumption Value by Country (2014-2019E) 11.9 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Production Analysis from 2014-2019E 12.4 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Import and Export from 2014-2019E 12.6 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market PEST Analysis 13 Latin America 13.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Production Analysis from 2014-2019E 13.4 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Consumption Analysis from 2014-2019E 13.5 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Import and Export from 2014-2019E 13.6 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Benign Prostatic Hyperplasia (BPH) Treatment by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Sales by Country (2014-2019E) 13.8.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Consumption Value by Country (2014-2019E) 13.9 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Production Analysis from 2014-2019E 14.4 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Import and Export from 2014-2019E 14.6 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market PEST Analysis 15 Future Forecast of the Global Benign Prostatic Hyperplasia (BPH) Treatment Market from 2018-2026 15.1 Future Forecast of the Global Benign Prostatic Hyperplasia (BPH) Treatment Market from 2019-2026 Segment by Region 15.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source

List of Tables and Figures Global Benign Prostatic Hyperplasia (BPH) Treatment Market Value ($) and Growth Rate of Benign Prostatic Hyperplasia (BPH) Treatment from 2014-2026 Global Benign Prostatic Hyperplasia (BPH) Treatment Production and Growth Rate Segment by Product Type from 2014-2026F Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate Segment by Application from 2014-2019E Figure Benign Prostatic Hyperplasia (BPH) Treatment Picture Table Product Specifications of Benign Prostatic Hyperplasia (BPH) Treatment Table Driving Factors for this Market Table Industry News of Benign Prostatic Hyperplasia (BPH) Treatment Market Figure Value Chain Status of Benign Prostatic Hyperplasia (BPH) Treatment Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Benign Prostatic Hyperplasia (BPH) Treatment Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Benign Prostatic Hyperplasia (BPH) Treatment Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure Alpha Blocker of Benign Prostatic Hyperplasia (BPH) Treatment Figure 5- Alpha Reductase Inhibitor of Benign Prostatic Hyperplasia (BPH) Treatment Figure Tadalafil of Benign Prostatic Hyperplasia (BPH) Treatment Figure Others of Benign Prostatic Hyperplasia (BPH) Treatment Table Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Benign Prostatic Hyperplasia (BPH) Treatment Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Hospital of Benign Prostatic Hyperplasia (BPH) Treatment Figure Clinic of Benign Prostatic Hyperplasia (BPH) Treatment Table Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Benign Prostatic Hyperplasia (BPH) Treatment Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Benign Prostatic Hyperplasia (BPH) Treatment Figure Online Channel of Benign Prostatic Hyperplasia (BPH) Treatment Table Pfizer, Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Pfizer, Inc. Sales and Growth Rate from 2014-2019E Figure Pfizer, Inc. Revenue ($) and Global Market Share from 2014-2019E Table Pfizer, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Astellas Pharma, Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Astellas Pharma, Inc. Sales and Growth Rate from 2014-2019E Figure Astellas Pharma, Inc. Revenue ($) and Global Market Share from 2014-2019E Table Astellas Pharma, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Merck & Co., Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Merck & Co., Inc. Sales and Growth Rate from 2014-2019E Figure Merck & Co., Inc. Revenue ($) and Global Market Share from 2014-2019E Table Merck & Co., Inc. Benign Prostatic Hyperplasia (BPH) Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Abbott Laboratories Profile (Company Name, Plants Distribution, Sales Region) Figure Abbott Laboratories Sales and Growth Rate from 2014-2019E Figure Abbott Laboratories Revenue ($) and Global Market Share from 2014-2019E Table Abbott Laboratories Benign Prostatic Hyperplasia (BPH) Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table GlaxoSmithKline plc Profile (Company Name, Plants Distribution, Sales Region) Figure GlaxoSmithKline plc Sales and Growth Rate from 2014-2019E Figure GlaxoSmithKline plc Revenue ($) and Global Market Share from 2014-2019E Table GlaxoSmithKline plc Benign Prostatic Hyperplasia (BPH) Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Allergan plc Profile (Company Name, Plants Distribution, Sales Region) Figure Allergan plc Sales and Growth Rate from 2014-2019E Figure Allergan plc Revenue ($) and Global Market Share from 2014-2019E Table Allergan plc Benign Prostatic Hyperplasia (BPH) Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Boehringer Ingelheim Pharma GmbH & Co. KG Profile (Company Name, Plants Distribution, Sales Region) Figure Boehringer Ingelheim Pharma GmbH & Co. KG Sales and Growth Rate from 2014-2019E Figure Boehringer Ingelheim Pharma GmbH & Co. KG Revenue ($) and Global Market Share from 2014-2019E Table Boehringer Ingelheim Pharma GmbH & Co. KG Benign Prostatic Hyperplasia (BPH) Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Teva Pharmaceutical Industries Limited Profile (Company Name, Plants Distribution, Sales Region) Figure Teva Pharmaceutical Industries Limited Sales and Growth Rate from 2014-2019E Figure Teva Pharmaceutical Industries Limited Revenue ($) and Global Market Share from 2014-2019E Table Teva Pharmaceutical Industries Limited Benign Prostatic Hyperplasia (BPH) Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Eli Lilly and Company Profile (Company Name, Plants Distribution, Sales Region) Figure Eli Lilly and Company Sales and Growth Rate from 2014-2019E Figure Eli Lilly and Company Revenue ($) and Global Market Share from 2014-2019E Table Eli Lilly and Company Benign Prostatic Hyperplasia (BPH) Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Sanofi Profile (Company Name, Plants Distribution, Sales Region) Figure Sanofi Sales and Growth Rate from 2014-2019E Figure Sanofi Revenue ($) and Global Market Share from 2014-2019E Table Sanofi Benign Prostatic Hyperplasia (BPH) Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Benign Prostatic Hyperplasia (BPH) Treatment Production Value ($) by Region from 2014-2019E Table Global Benign Prostatic Hyperplasia (BPH) Treatment Production Value Share by Region from 2014-2019E Table Global Benign Prostatic Hyperplasia (BPH) Treatment Production by Region from 2014-2019E Table Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption Value ($) by Region from 2014-2019E Table Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption by Region from 2014-2019E Table North America Benign Prostatic Hyperplasia (BPH) Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Benign Prostatic Hyperplasia (BPH) Treatment Import and Export from 2014-2019E Table North America Benign Prostatic Hyperplasia (BPH) Treatment Value ($) by Type (2014-2019E) Table North America Benign Prostatic Hyperplasia (BPH) Treatment Production by Type (2014-2019E) Table North America Benign Prostatic Hyperplasia (BPH) Treatment Consumption by Application (2014-2019E) Table North America Benign Prostatic Hyperplasia (BPH) Treatment Consumption by Country (2014-2019E) Table North America Benign Prostatic Hyperplasia (BPH) Treatment Consumption Value ($) by Country (2014-2019E) Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Market PEST Analysis Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Import and Export from 2014-2019E Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Value ($) by Type (2014-2019E) Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Production by Type (2014-2019E) Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Consumption by Application (2014-2019E) Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Consumption by Country (2014-2019E) Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Consumption Value ($) by Country (2014-2019E) Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Market PEST Analysis Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Import and Export from 2014-2019E Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Value ($) by Type (2014-2019E) Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Production by Type (2014-2019E) Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Consumption by Application (2014-2019E) Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Consumption by Country (2014-2019E) Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market PEST Analysis Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Import and Export from 2014-2019E Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Value ($) by Type (2014-2019E) Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Production by Type (2014-2019E) Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Consumption by Application (2014-2019E) Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Consumption by Country (2014-2019E) Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Consumption Value ($) by Country (2014-2019E) Figure Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market PEST Analysis Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Import and Export from 2014-2019E Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Value ($) by Type (2014-2019E) Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Production by Type (2014-2019E) Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Consumption by Application (2014-2019E) Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Consumption by Country (2014-2019E) Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market PEST Analysis Table Global Benign Prostatic Hyperplasia (BPH) Treatment Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Benign Prostatic Hyperplasia (BPH) Treatment Production and Growth Rate Forecast by Region (2019-2026) Table Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Benign Prostatic Hyperplasia (BPH) Treatment Production and Growth Rate Forecast by Type (2019-2026) Table Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate Forecast by Application (2019-2026)